Linguistic validation of Japanese version of International Prostate Symptom Score and BPH Impact Index

Japanese Journal of Urology

Volumn 93, Issue 6, 2002, Pages 669-680

  Homma, Yukio ^a   Tsukamoto, Taiji ^a   Yasuda, Kousaku ^a   Ozono, Seiichiro ^a   Yoshida, Masaki ^a   Shinji, Megumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Benign prostatic hyperplasia; Symptom score; Validation

Indexed keywords

ARTICLE; BPH IMPACT INDEX; CLINICAL ARTICLE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; JAPAN; LANGUAGE; MALE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; VALIDATION PROCESS;

EID: 0036745017     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.93.669     Document Type: Article

References (17)

1. Barry, M.J., Fowler, F.J., Jr., O'Leary, M.P., Bruskewitz. R.C., Holtgrewe, H.L., Mebust, W.K. and Cockett, A.T.: The American Urological Association symptom index for benign prostatic hyperplasia. Measurement Committee of The American Urological Association. J. Urol., 148, 1549-1557. 1992.
2. Barry, M.J., Fowler, F.J., Jr., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L. and Mebust, W.K.: Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med. Care, 33. AS145-155, 1995.
3. Recommendations of the 2nd International Consensus Committee. In: Proceedings of the International Consultation on Benign Prostatic Hyperplasia. Edited by A.T.K. Cockett, S. Khoury, Y. Aso, C. Chatelain, L. Denis, K. Griffiths, G. Murphy. Jersey: Scientific Communication International Ltd. p553-672, 1994.
4. Fukuhara, S., Ware, J.E. Jr., Kosinski, M., Wada, S. and Gandek, B.: Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J. Clin. Epidemiol., 51, 1045-1053, 1998.
5. Hald, T., Nordling, J., Andersen, J.T., Bilde, T., Meyhoff, H.H. and Walter, S.: A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand. J. Urol. Nephrol. Suppl., 138, 59-62, 1991.
6. Donovan, J.L., Abrams, P., Peters, T.J., Kay, H.E., Reynard, J., Chapple, C., De La Rosette, J.J. and Kondo, A.: The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br. J. Urol., 77, 554-562, 1996.
7. Barry, M.J., Fowler, F.J., Jr., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L., Mebust, W.K. and Cockett, A.T.: Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. J. Urol., 148, 1558-1563, 1992
8. Barry, M.J., Williford, W.O., Chang, Y., Machi, M., Jones, K.M. Waker-Corkery, E. and Lepor, H.: Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J. Urol., 154, 1770-1774, 1995.
9. Barry, M.J., Williford, W.O., Fowler, F.J., Jr., Jones, K.M. and Lepor, H.: Filling and voiding symptoms in the American urological association symptom index: The value of their distinction in a veterans affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia. J. Urol., 164:1559-1564, 2000.
10. Badia, X., Garcia-Losa, M. and Dal-Re, R.: Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur. Urol., 31, 129-140, 1997.
11. Quek, K.F., Low, W.Y., Razack, A.H. and Loh, C.S.: Reliability and validity of the International Prostate Symptom Score in a Malaysian population. BJU. Int., 88, 21-25, 2001.
12. Guillemin, F., Bombardier, C. and Beaton, D.: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol., 46, 1417-1432, 1993.